Toth Financial Advisory’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Toth Financial Advisory's TVTX Position: Q3 2026 in Review
Toth Financial Advisory opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 5 shares worth $295. The stake represents ﹤0.01% of the portfolio and ranks #1008 among its holdings.
345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Toth Financial Advisory held 5 shares of Travere Therapeutics worth $295 as of Q3 2026.
- Travere Therapeutics was a new Toth Financial Advisory position in Q3 2026.
- Travere Therapeutics made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #1008 holding.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.